Outset Medical Return on Tangible Equity 2019-2024 | OM
Outset Medical Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2024-12-31 | $-0.13B | $0.03B | -216.03% |
2024-09-30 | $-0.14B | $0.05B | -169.37% |
2024-06-30 | $-0.16B | $0.07B | -145.54% |
2024-03-31 | $-0.17B | $0.09B | -122.69% |
2023-12-31 | $-0.17B | $0.12B | -102.67% |
2023-09-30 | $-0.18B | $0.15B | -87.83% |
2023-06-30 | $-0.17B | $0.18B | -73.59% |
2023-03-31 | $-0.17B | $0.22B | -64.70% |
2022-12-31 | $-0.16B | $0.25B | -55.25% |
2022-09-30 | $-0.16B | $0.28B | -49.85% |
2022-06-30 | $-0.15B | $0.31B | -42.25% |
2022-03-31 | $-0.14B | $0.35B | -35.38% |
2021-12-31 | $-0.13B | $0.37B | -34.43% |
2021-09-30 | $-0.10B | $0.41B | -28.17% |
2021-06-30 | $-0.12B | $0.43B | -32.65% |
2021-03-31 | $-0.11B | $0.31B | -45.66% |
2020-12-31 | $-0.08B | $0.33B | -46.85% |
2020-06-30 | $-0.04B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.070B | $0.114B |
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
Tempus AI (TEM) | United States | $11.278B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.503B | 70.35 |
IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
Privia Health (PRVA) | United States | $3.050B | 208.50 |
Enovis (ENOV) | United States | $2.060B | 11.48 |
Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
Schrodinger (SDGR) | United States | $1.722B | 0.00 |
Phreesia (PHR) | United States | $1.510B | 0.00 |
Omnicell (OMCL) | United States | $1.310B | 23.11 |
Azenta (AZTA) | United States | $1.258B | 58.45 |
10x Genomics (TXG) | United States | $1.148B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
Talkspace (TALK) | United States | $0.499B | 149.00 |
Veradigm (MDRX) | United States | $0.455B | 0.00 |
Claritev (CTEV) | United States | $0.450B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
TruBridge (TBRG) | United States | $0.376B | 834.67 |
Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
Pulmonx (LUNG) | United States | $0.138B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
CareCloud (CCLD) | United States | $0.089B | 3.39 |
111 (YI) | China | $0.067B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.042B | 0.00 |
Zhongchao (ZCMD) | China | $0.032B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
Precipio (PRPO) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |